Suppr超能文献

静脉血栓栓塞症的治疗

The treatment of venous thromboembolism.

作者信息

Hirsh J

机构信息

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

出版信息

Nouv Rev Fr Hematol (1978). 1988;30(3):149-53.

PMID:3047668
Abstract

Venous thromboembolism is usually treated with heparin followed by oral anticoagulants for approximately 3 months. The optimal length of heparin therapy is uncertain. There is now good evidence that treatment failures are associated with inadequate heparin effects. Heparin can be administered with similar safety and effectiveness by either intravenous infusion or 2 hourly subcutaneous injection. Oral anticoagulant therapy is effective and safe if given in a dose which prolongs the prothrombin time to an international normalized ratio of 2.0 to 2.5. Thrombolytic therapy is indicated in patients with major pulmonary embolism and in selected patients with recent acute venous thrombosis. Vena caval interruption is usually confined to patients who have contraindications to anticoagulant therapy. Surgical removal of thromboembolic obstruction should be considered in selected patients with thromboembolic pulmonary hypertension.

摘要

静脉血栓栓塞症通常先用肝素治疗,随后口服抗凝剂约3个月。肝素治疗的最佳时长尚不确定。目前有充分证据表明,治疗失败与肝素效果不足有关。肝素通过静脉输注或每2小时皮下注射给药,安全性和有效性相似。如果口服抗凝剂剂量能将凝血酶原时间延长至国际标准化比值为2.0至2.5,则其治疗有效且安全。对于大面积肺栓塞患者以及部分近期发生急性静脉血栓形成的患者,需进行溶栓治疗。腔静脉阻断通常仅限于有抗凝治疗禁忌证的患者。对于部分血栓栓塞性肺动脉高压患者,应考虑手术清除血栓栓塞性梗阻。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验